See also this year's filing and all EDGAR filings for this company.
PDF Report 0001595097_2023_Corbus_Pharmaceuticals_Holdings_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001595097, Corbus Pharmaceuticals Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 60,181,102 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,613,815 |
| 3 | remainder_Assets | 4,517,023 |
| 4 | LiabilitiesCurrent | 12,639,938 |
| 5 | LiabilitiesNoncurrent | 20,681,985 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,698,619 |
| 9 | ResearchAndDevelopmentExpense | 16,136,826 |
| 10 | remainder_Expenses | 5,000,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,511,458 |
| 13 | remainder_ComprehensiveNetIncome | -63,647 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 66,311,940 |
| 1 | Liabilities | 33,321,923 |
| 2 | Expenses | 39,835,445 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 32,990,017 |
| 5 | NetIncome | -42,346,903 |
| 6 | ComprehensiveNetIncome | -42,378,726 |
| 7 | BaseVar | 71,022,206 |
| 8 | EconomicCapitalRatio | 0.288 |
Edgar->Model Mapping
Feature Distribution
Change over Time
